Daily News Podcast

Lorcaserin shows cardiovascular safety

Publish date: August 27, 2018

 

Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Variation doesn’t mean quality when it comes to diet
MDedge Dermatology
Medicare Advantage pushback
MDedge Dermatology
Psoriasis registry study provides more data on infliximab’s infection risk
MDedge Dermatology
FDA approves first EpiPen generic
MDedge Dermatology
Cardiovascular risk management supported for type 2 diabetes
MDedge Dermatology
Sleepio app tied to reducing insomnia, depression
MDedge Dermatology
Telangiectatic Patch on the Neck
MDedge Dermatology
5 digital HIPAA myths
MDedge Dermatology
Screen for cervical cancer based on age, risk
MDedge Dermatology
Is it time for PCPs to take over chronic HCV?
MDedge Dermatology